Crucell's P2P Acquisition

Crucell raised a round of funding on October 06, 2010. Investors include Johnson & Johnson.

Crucell (Euronext, NASDAQ: CRXL; Swiss Exchange: SW CRX) is a biotechnology company focused on research, development and worldwide marketing of vaccines and antibodies that prevent and treat infectiou…

Articles about Crucell's P2P Acquisition: